Sumitomo Mitsui Trust Holdings, Inc. Arcturus Therapeutics Holdings Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $145 Billion
- Q4 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 2,065,050 shares of ARCT stock, worth $35 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,065,050
Previous 2,275,715
9.26%
Holding current value
$35 Million
Previous $52.8 Million
33.65%
% of portfolio
0.02%
Previous 0.04%
Shares
23 transactions
Others Institutions Holding ARCT
# of Institutions
174Shares Held
25.5MCall Options Held
195KPut Options Held
133K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$79.7 Million0.25% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$45 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.32MShares$39.3 Million0.62% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.1MShares$35.7 Million0.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.58MShares$26.8 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $451M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...